
ATEX Valuation
Anterix Inc
- Overview
- Forecast
- Valuation
- Earnings
ATEX Relative Valuation
ATEX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ATEX is overvalued; if below, it's undervalued.
Historical Valuation
Anterix Inc (ATEX) is now in the Fair zone, suggesting that its current forward PS ratio of 71.90 is considered Fairly compared with the five-year average of -22.74. The fair price of Anterix Inc (ATEX) is between 5.49 to 92.74 according to relative valuation methord.
Relative Value
Fair Zone
5.49-92.74
Current Price:22.20
Fair
-48.05
PE
1Y
3Y
5Y
Trailing
Forward
-10.84
EV/EBITDA
Anterix Inc. (ATEX) has a current EV/EBITDA of -10.84. The 5-year average EV/EBITDA is -20.21. The thresholds are as follows: Strongly Undervalued below -33.08, Undervalued between -33.08 and -26.64, Fairly Valued between -13.77 and -26.64, Overvalued between -13.77 and -7.33, and Strongly Overvalued above -7.33. The current Forward EV/EBITDA of -10.84 falls within the Overvalued range.
-39.87
EV/EBIT
Anterix Inc. (ATEX) has a current EV/EBIT of -39.87. The 5-year average EV/EBIT is -18.59. The thresholds are as follows: Strongly Undervalued below -48.35, Undervalued between -48.35 and -33.47, Fairly Valued between -3.71 and -33.47, Overvalued between -3.71 and 11.17, and Strongly Overvalued above 11.17. The current Forward EV/EBIT of -39.87 falls within the Undervalued range.
71.99
PS
Anterix Inc. (ATEX) has a current PS of 71.99. The 5-year average PS is 192.18. The thresholds are as follows: Strongly Undervalued below -160.89, Undervalued between -160.89 and 15.64, Fairly Valued between 368.71 and 15.64, Overvalued between 368.71 and 545.24, and Strongly Overvalued above 545.24. The current Forward PS of 71.99 falls within the Historic Trend Line -Fairly Valued range.
7.65
P/OCF
Anterix Inc. (ATEX) has a current P/OCF of 7.65. The 5-year average P/OCF is -10.37. The thresholds are as follows: Strongly Undervalued below -694.00, Undervalued between -694.00 and -352.19, Fairly Valued between 331.44 and -352.19, Overvalued between 331.44 and 673.26, and Strongly Overvalued above 673.26. The current Forward P/OCF of 7.65 falls within the Historic Trend Line -Fairly Valued range.
10.88
P/FCF
Anterix Inc. (ATEX) has a current P/FCF of 10.88. The 5-year average P/FCF is -15.56. The thresholds are as follows: Strongly Undervalued below -166.65, Undervalued between -166.65 and -91.11, Fairly Valued between 59.99 and -91.11, Overvalued between 59.99 and 135.53, and Strongly Overvalued above 135.53. The current Forward P/FCF of 10.88 falls within the Historic Trend Line -Fairly Valued range.
Anterix Inc (ATEX) has a current Price-to-Book (P/B) ratio of 2.15. Compared to its 3-year average P/B ratio of 3.81 , the current P/B ratio is approximately -43.61% higher. Relative to its 5-year average P/B ratio of 4.00, the current P/B ratio is about -46.27% higher. Anterix Inc (ATEX) has a Forward Free Cash Flow (FCF) yield of approximately -7.30%. Compared to its 3-year average FCF yield of 0.55%, the current FCF yield is approximately -1423.03% lower. Relative to its 5-year average FCF yield of -0.02% , the current FCF yield is about 40013.76% lower.
2.26
P/B
Median3y
3.81
Median5y
4.00
-7.29
FCF Yield
Median3y
0.55
Median5y
-0.02
Competitors Valuation Multiple
The average P/S ratio for ATEX's competitors is 18.11, providing a benchmark for relative valuation. Anterix Inc Corp (ATEX) exhibits a P/S ratio of 71.99, which is 297.56% above the industry average. Given its robust revenue growth of -7.02%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ATEX decreased by 36.71% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 4.11 to 14.16.
The secondary factor is the Revenue Growth, contributed -7.02%to the performance.
Overall, the performance of ATEX in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

LYTS
LSI Industries Inc
23.660
USD
+15.98%

PLOW
Douglas Dynamics Inc
33.850
USD
+3.80%

SPFI
South Plains Financial Inc
41.315
USD
+4.36%

HTBK
Heritage Commerce Corp
10.090
USD
+3.59%

NOA
North American Construction Group Ltd
13.560
USD
+1.88%

KURA
Kura Oncology Inc
7.650
USD
+2.82%

CRGX
CARGO Therapeutics Inc
0
USD
-1.57%

NAT
Nordic American Tankers Ltd
3.050
USD
+0.66%

ALTI
AlTi Global, Inc
4.340
USD
+5.34%

BTBT
Bit Digital Inc
2.880
USD
+5.88%
FAQ

Is Anterix Inc (ATEX) currently overvalued or undervalued?
Anterix Inc (ATEX) is now in the Fair zone, suggesting that its current forward PS ratio of 71.90 is considered Fairly compared with the five-year average of -22.74. The fair price of Anterix Inc (ATEX) is between 5.49 to 92.74 according to relative valuation methord.

What is Anterix Inc (ATEX) fair value?

How does ATEX's valuation metrics compare to the industry average?

What is the current P/B ratio for Anterix Inc (ATEX) as of Aug 23 2025?

What is the current FCF Yield for Anterix Inc (ATEX) as of Aug 23 2025?

What is the current Forward P/E ratio for Anterix Inc (ATEX) as of Aug 23 2025?
